Clinical Trial Detail

NCT ID NCT02241187
Title Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan-Kettering Cancer Center
Indications

pancreatic ductal adenocarcinoma

Therapies

Cetuximab + PEGPH20

Age Groups: adult

No variant requirements are available.